Moreover, chalcoplatin, when combined with cisplatin and chalcone, increased the expression of p53 protein, demonstrating better anti-tumor activity than cisplatin in p53 wild-type cancer cells and effectively overcoming cisplatin resistance. Here, TP53 is linked to neoplasm.